Investment opportunities

V4Cure develops disruptive medicine form a drug discovery platform with animal venoms.

Transforming a simple blood draw into real-time intelligence to guide personalized cancer care.

Unique technology for oral RNA to the gut; locally switching off Crohn’s & Colitis inflammation to solve major gaps in a $30B+ market.

AbTx develops anti-cancer treatments – capable of better penetrating solid tumors (pancreas) – thus improving their effectiveness.

Shaping the future of gene delivery, using the carrying power of extracellular vesicles & the RNA-loading capacity of lipid nanovectors

Kervalion is transforming bone reconstruction, starting with dental implants, with a biobased graft that cuts healing time and operations.

Therapeutic platform for automating rehabilitation through VR and AI: increasing therapeutic efficacy by 35%

Ox-01 is the missing piece in stroke treatment – a breakthrough therapy that protects the brain and saves lives when stroke strikes

The first rapid and reliable kit for the early diagnosis of Multiple Sclerosis in blood: a new era in neurological diagnosis

Transforming Cell and Gene Therapy from ex vivo to in situ delivery, to provide access to more patients, faster

NX210c, a drug candidate in phase 2 trial to fight Amyotrophic Lateral Sclerosis (ALS) and a broad range of neurodegenerative diseases

GlioHook: The first device to trap cells that cause glioblastoma relapse and increase response to standard treatment